Analyst firms · Barclays · QURE
Barclays QURE price target and rating history
uniQure N.V. (QURE) · Health Care
Barclays rates uniQure N.V. (QURE) Equal Weight with a $28 price target, as of its latest action on Oct 5, 2026. It has published 3 rating actions on QURE since January 2026, including 1 upgrade and 1 downgrade. Across 6 firms with a QURE price target in the last 12 months, the median target is $47.50. Barclays's $28 is 41% below that.
- Current rating
- Equal Weight
- Price target
- $28
- Median target, all firms
- $47.50
- Actions on QURE
- 3
Barclays price target on QURE
Every Barclays rating on QURE
- Oct 5, 2026
- Jun 18, 2026
- Jan 28, 2026
How other firms rate QURE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $28 | Oct 5, 2026 |
| William Blair | Outperform | Sep 2, 2026 | |
| Wolfe Research | Outperform | $65 | Jul 30, 2026 |
| Cantor Fitzgerald | Overweight | $61 | Jun 17, 2026 |
| Mizuho | Outperform | $35 | Mar 11, 2026 |
| RBC Capital Markets | Outperform | $35 | Mar 9, 2026 |
| Wells Fargo | Overweight | $60 | Mar 9, 2026 |
Questions about Barclays and QURE
- What is Barclays's price target for QURE?
- Barclays's latest stated price target for uniQure N.V. (QURE) is $28, from its action on Oct 5, 2026.
- What is Barclays's rating on QURE?
- Barclays rates QURE Equal Weight, a neutral rating, as of Oct 5, 2026.
- When did Barclays last change its view on QURE?
- On Oct 5, 2026, Barclays downgrades to Equal Weight from Overweight, price target $28.
- How does Barclays's QURE target compare with other analysts?
- Across 6 firms with a QURE price target in the last 12 months, the median target is $47.50. Barclays's $28 is 41% below that.
More QURE rating histories
All Barclays ratingsQURE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.